Personalis

-$0.39 (-1.92%) Today

$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Personalis and other ETFs, options, and stocks.

About PSNL

Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A.

CEO

John S. West

Employees

235

Headquarters

Menlo Park, California

Founded

2011

PSNL Key Statistics

Market Cap

885.59M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

421.25K

High Today

$20.62

Low Today

$19.92

Open Price

$20.62

Volume

448.35K

52 Week High

$53.46

52 Week Low

$16.54

PSNL News

Benzinga8h

Notable Personalis Insider Makes $1.9M Sale

Stephen John West, President And CEO at Personalis (NASDAQ:PSNL), made a large insider sell on October 12, according to a new SEC filing. What Happened: A Form

Analyst Ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell

PSNL Earnings

-$0.39

-$0.26

-$0.13

$0.00

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Nov 4, After Hours

Why Robinhood?

Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. View more

Notable Personalis Insider Makes $1.9M Sale

88%

Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A.